查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401846

到 2030 年的神经技术市场预测：按产品、病理状况、最终用户和地区进行的全球分析

Neurotechnology Market Forecasts to 2030 - Global Analysis By Product, Condition, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球神经技术市场规模为 145.5 亿美元，预计到 2030 年将达到 353.1 亿美元，预测期内复合年增长率为 13.5%。

神经技术是指利用工程学、电子学、电脑科学和其他学科来理解、修復、替换、增强或影响神经系统的功能。这个跨学科领域涵盖了与大脑和神经系统相互作用的广泛技术和应用。它有望了解大脑并开发医疗保健、通讯和人类增强方面的创新应用。

根据联合国估计，全球每年约有 10 亿人受到神经病变的影响。

神经系统疾病盛行率增加

阿兹海默症、帕金森氏症、癫痫和各种形式的神经病变疼痛等神经系统疾病在世界各地变得越来越普遍。人口高龄化、生活方式的改变和环境因素导致这些疾病的发生率上升。总体而言，神经系统疾病的日益普及正在创造对先进有效解决方案的需求，推动神经技术市场的创新和成长。

道德和隐私问题

神经技术通常涉及高度个人化和敏感的大脑资料的收集和分析。确定谁拥有和控制神经技术设备产生的资料是一项道德和法律挑战。解决此类道德和隐私问题对于获得公众信任、确保负责任的发展以及确保神经技术创新的广泛接受至关重要。

神经科学研究进展

神经科学的进步有助于识别和理解与各种神经系统疾病相关的生物标记。神经科学的持续研究有助于更深入地了解大脑功能。神经科学研究和神经技术发展之间的共生关係是理解、诊断和治疗各种神经系统疾病的创新解决方案不断发展的驱动力。随着神经科学不断揭开大脑的奥秘，它为具有多种应用的神经技术的进步提供了丰富的基础。

开发成本高

神经技术通常整合多个领域的专业知识，例如电脑科学、工程和神经病学。开发神经技术解决方案以确保安全性、有效性和法规遵循需要透过临床试验进行彻底的测试。这种资源集中研究会显着增加总开发成本。此外，与智慧财产权、长期测试和检验以及针对个别变化的客製化相关的费用增加了总成本并阻碍了市场开拓。

COVID-19 的影响

与许多其他领域一样，神经技术领域的研发活动因疫情造成的干扰而出现了延误。实验室和研究设施面临关闭和能力限制，影响了创新的步伐。这次疫情也引起了人们对心理健康问题的关注，提高了人们对监测和解决心理健康问题重要性的认识。此外，疫情增加了政府和私人投资者对医疗保健技术融资的兴趣，吸引了更多资本进入该行业。

神经復健领域预计在预测期内规模最大

神经復健领域预计将出现良好的成长。神经復健是一个专门的復健领域，专注于神经病变和损伤患者的恢復和改善。神经復健旨在提高运动技能、平衡、协调和精细运动技能等功能能力。其他好处，包括心理健康、生活品质提高、长期独立和疼痛管理，正在推动这一领域的发展。

认知障碍产业预计在预测期内复合年增长率最高

认知障碍产业预计在预测期内复合年增长率最高。神经技术工具提供认知障碍的客观生物标记。脑影像技术等神经技术工具可以帮助早期发现和诊断认知障碍。这种方法可以帮助个人学习大脑功能的自我调节并提高认知能力。此外，个人化治疗计划、增强的神经可塑性、治疗效果监测和生活品质改善等因素也为该细分市场提供了有利的成长。

占有率最大的地区

预计亚太地区在预测期内将占据最大的市场占有率。亚太地区对医疗保健技术的兴趣和投资正在增加。许多主要企业都位于该地区，包括 NeuroSky、NeuroLifeSciences、NeuClonec、Neuro Device Group 和 Neural Analytics。提高对神经技术益处的认识和教育，以及该地区神经病变的上升，进一步支持了该地区的市场扩张。

复合年增长率最高的地区：

预计欧洲在预测期内的复合年增长率最高。新兴国家积极致力于神经技术领域的研发。欧洲的神经技术领域正在吸引新创公司和老牌新兴企业的投资和资助。此外，在欧洲，神经技术的研究和应用强调伦理考量。该地区不断增加的投资和研究合作正在促进神经技术市场的成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球神经技术市场：副产品

  • 神经感应
  • 神经假体
  • 神经復健
  • 神经刺激
    • 荐骨神经刺激器
    • 迷走神经刺激设备
    • 胃电刺激设备
    • 脊髓刺激设备
    • 深部脑部刺激器
    • 经皮神经电刺激 (TENS)
  • 其他产品

第六章全球神经科技市场：依病理

  • 疼痛治疗
  • 尿失禁和大便失禁
  • 认知障碍
  • 帕金森氏症
  • 忧郁症
  • 癫痫
  • 睡眠失调
  • 听力状况
  • 自发性震颤
  • 其他条件

第七章 全球神经科技市场：依最终用户分类

  • 医院
  • 居家照护设施
  • 门诊手术中心
  • 其他最终用户

第八章全球神经技术市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • General Electric
  • Hitachi Medical
  • Siemens Healthcare
  • Elekta
  • Koninklijke Philips
  • Canon Medical Systems
  • Magstim
  • Allengers Medical
  • Abbott Laboratories
  • Neuralink Corporation
  • Boston Scientific Corporation
  • Advanced Bionics AG（Sonova）
  • Tristan Technologies
  • Shimadzu
  • Medtronic PLC
  • Blackrock Microsystems
  • NeuroVigil Inc.
  • Integra LifeSciences
  • Natus medical Incorporated
  • Nihon Kohden Corporation
Product Code: SMRC24366

According to Stratistics MRC, the Global Neurotechnology Market is accounted for $14.55 billion in 2023 and is expected to reach $35.31 billion by 2030 growing at a CAGR of 13.5% during the forecast period. Neurotechnology refers to the use of engineering, electronics, computer science, and other disciplines to understand, repair, replace, enhance, or otherwise influence the functioning of the nervous system. This multidisciplinary field encompasses a wide range of technologies and applications that interact with the brain and the nervous system. It holds promise for both understanding the brain and developing innovative applications for healthcare, communication, and human augmentation.

According to the United Nations estimates, around 1 billion individuals worldwide are affected by neurological disorders every year.

Market Dynamics:

Driver:

Increasing prevalence of neurological disorders

Neurological disorders, such as Alzheimer's disease, Parkinson's disease, epilepsy, and various forms of neuropathic pain, are becoming more prevalent globally. The aging population, lifestyle changes, and environmental factors contribute to the increasing incidence of these disorders. Overall, the increasing prevalence of neurological disorders creates a demand for advanced and effective solutions, driving innovation and growth in the neurotechnology market.

Restraint:

Ethical and privacy concerns

Neurotechnology often involves the collection and analysis of highly personal and sensitive brain data. Determining who owns and controls the data generated by neurotechnological devices is an ethical and legal challenge. Addressing these ethical and privacy concerns is critical for gaining public trust, ensuring responsible development, and fostering widespread acceptance of neurotechnological innovations.

Opportunity:

Advancements in neuroscience research

Advances in neuroscience help identify and understand biomarkers associated with different neurological conditions. Ongoing research in neuroscience contributes to a deeper understanding of brain function. The symbiotic relationship between neuroscience research and neurotechnology development is a driving force behind the continuous evolution of innovative solutions for understanding, diagnosing, and treating various neurological conditions. As neuroscience continues to uncover the mysteries of the brain, it provides a rich foundation for the advancement of neurotechnologies with diverse applications.

Threat:

High development costs

Integration of expertise from several fields, including computer science, engineering, and neurology, is common in neurotechnology. Thorough testing through clinical trials is necessary for developing neurotechnological solutions to guarantee safety, effectiveness, and regulatory compliance. These resource-intensive studies have the potential to greatly increase total development costs. Furthermore, expenditures associated with intellectual property, lengthy testing and validation, and customisation for individual variations enhances total costs and impedes market development.

COVID-19 Impact

The neurotechnology sector, like many others, have experienced delays in research and development activities due to disruptions caused by the pandemic. Laboratories and research facilities faced closures or limitations in capacity, affecting the pace of innovation. Also, the pandemic has brought attention to mental health issues, and there is a growing awareness of the importance of monitoring and addressing mental well-being. Additionally, governments and private investors have shown an increased interest in funding healthcare technologies due to the pandemic which have attracted additional funding in the sector.

The neurorehabilitation segment is expected to be the largest during the forecast period

The neurorehabilitation segment is estimated to have a lucrative growth. Neurorehabilitation is a specialized field of rehabilitation focused on the recovery and improvement of individuals with neurological disorders or injuries. Neurorehabilitation aims to enhance functional abilities such as mobility, balance, coordination, and fine motor skills. Additionally, its benefits such as psychological well-being, improved quality of life, long-term independence and pain management boost the segment growth.

The cognitive disorders segment is expected to have the highest CAGR during the forecast period

The cognitive disorders segment is anticipated to witness the highest CAGR growth during the forecast period. Neurotechnological tools provide objective biomarkers for cognitive disorders. Neurotechnology tools, such as brain imaging techniques, can help in early detection and diagnosis of cognitive disorders. This approach helps individuals learn to self-regulate their brain function and improve cognitive performance. Also, its elements such as personalized treatment plans, enhancing neuroplasticity, monitoring treatment efficacy and quality of life improvements provides lucrative growth to the segment.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period. The Asia Pacific region has shown increasing interest and investment in healthcare technologies. The region is home for many key players such as NeuroSky, NeuroLifeSciences, NeuClonec, Neuro Device Group and Neural Analytics. The region's increased awareness and education about the benefits of neurotechnology along with rising incidence of neurological disorders is further propelling the market expansion in this region.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period. European countries are actively involved in research and development in the field of neurotechnology. The neurotechnology sector in Europe has attracted investments and funding for both start-ups and established companies. Also, Europe places a strong emphasis on ethical considerations in neurotechnology research and application. The rising investments and collaborations in the region contribute to the growth of the neurotechnology market.

Key players in the market:

Some of the key players profiled in the Neurotechnology Market include General Electric, Hitachi Medical, Siemens Healthcare, Elekta, Koninklijke Philips, Canon Medical Systems, Magstim, Allengers Medical, Abbott Laboratories, Neuralink Corporation, Boston Scientific Corporation, Advanced Bionics AG (Sonova), Tristan Technologies, Shimadzu, Medtronic PLC, Blackrock Microsystems, NeuroVigil Inc., Integra LifeSciences, Natus medical Incorporated and Nihon Kohden Corporation.

Key Developments:

In October 2023, Canon launched its innovative solution "nanoimprint lithography" system. The system is expected to represent the company's competitive response to ASML, a Dutch firm, a force in the extreme ultraviolet (EUV) lithography machine sector.

In July 2022, GE Healthcare, a global medical technology, diagnostics, and digital solutions innovator, announced the launch of its 5G Innovation Lab in India and across the globe. The lab is designed to position GE Healthcare advances in patient care and to bring cutting-edge technology to rural and sub-urban regions.

In March 2022, Siemens Healthineers introduced its unique solutions in MRI and CT portfolio- MAGNETOM Free.Star and NAEOTOM Alpha®. These latest additions in their portfolio truly reflect their purpose "We pioneer breakthroughs in healthcare For Everyone & Everywhere."

Products Covered:

  • Neurosensing
  • Neuroprostheses
  • Neurorehabilitation
  • Neurostimulation
  • Others Products

Conditions Covered:

  • Pain Treatment
  • Urinary & Fecal Incontinence
  • Cognitive Disorders
  • Parkinson's Disease
  • Depression
  • Epilepsy
  • Sleep Disorder
  • Hearing Conditions
  • Essential Tremor
  • Other Conditions

End Users Covered:

  • Hospitals
  • Homecare Facilities
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurotechnology Market, By Product

  • 5.1 Introduction
  • 5.2 Neurosensing
  • 5.3 Neuroprostheses
  • 5.4 Neurorehabilitation
  • 5.5 Neurostimulation
    • 5.5.1 Sacral Nerve Stimulator
    • 5.5.2 Vagus Nerve Stimulator
    • 5.5.3 Gastric Electric Stimulator
    • 5.5.4 Spinal Cord Stimulator
    • 5.5.5 Deep Brain Stimulator
    • 5.5.6 Transcutaneous Electrical Nerve Stimulation (TENS)
  • 5.6 Other Products

6 Global Neurotechnology Market, By Condition

  • 6.1 Introduction
  • 6.2 Pain Treatment
  • 6.3 Urinary & Fecal Incontinence
  • 6.4 Cognitive Disorders
  • 6.5 Parkinson's Disease
  • 6.6 Depression
  • 6.7 Epilepsy
  • 6.8 Sleep Disorder
  • 6.9 Hearing Conditions
  • 6.10 Essential Tremor
  • 6.11 Other Conditions

7 Global Neurotechnology Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Homecare Facilities
  • 7.4 Ambulatory Surgical Centers
  • 7.5 Other End Users

8 Global Neurotechnology Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 General Electric
  • 10.2 Hitachi Medical
  • 10.3 Siemens Healthcare
  • 10.4 Elekta
  • 10.5 Koninklijke Philips
  • 10.6 Canon Medical Systems
  • 10.7 Magstim
  • 10.8 Allengers Medical
  • 10.9 Abbott Laboratories
  • 10.10 Neuralink Corporation
  • 10.11 Boston Scientific Corporation
  • 10.12 Advanced Bionics AG (Sonova)
  • 10.13 Tristan Technologies
  • 10.14 Shimadzu
  • 10.15 Medtronic PLC
  • 10.16 Blackrock Microsystems
  • 10.17 NeuroVigil Inc.
  • 10.18 Integra LifeSciences
  • 10.19 Natus medical Incorporated
  • 10.20 Nihon Kohden Corporation

List of Tables

  • Table 1 Global Neurotechnology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neurotechnology Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Neurotechnology Market Outlook, By Neurosensing (2021-2030) ($MN)
  • Table 4 Global Neurotechnology Market Outlook, By Neuroprostheses (2021-2030) ($MN)
  • Table 5 Global Neurotechnology Market Outlook, By Neurorehabilitation (2021-2030) ($MN)
  • Table 6 Global Neurotechnology Market Outlook, By Neurostimulation (2021-2030) ($MN)
  • Table 7 Global Neurotechnology Market Outlook, By Sacral Nerve Stimulator (2021-2030) ($MN)
  • Table 8 Global Neurotechnology Market Outlook, By Vagus Nerve Stimulator (2021-2030) ($MN)
  • Table 9 Global Neurotechnology Market Outlook, By Gastric Electric Stimulator (2021-2030) ($MN)
  • Table 10 Global Neurotechnology Market Outlook, By Spinal Cord Stimulator (2021-2030) ($MN)
  • Table 11 Global Neurotechnology Market Outlook, By Deep Brain Stimulator (2021-2030) ($MN)
  • Table 12 Global Neurotechnology Market Outlook, By Transcutaneous Electrical Nerve Stimulation (TENS) (2021-2030) ($MN)
  • Table 13 Global Neurotechnology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 14 Global Neurotechnology Market Outlook, By Condition (2021-2030) ($MN)
  • Table 15 Global Neurotechnology Market Outlook, By Pain Treatment (2021-2030) ($MN)
  • Table 16 Global Neurotechnology Market Outlook, By Urinary & Fecal Incontinence (2021-2030) ($MN)
  • Table 17 Global Neurotechnology Market Outlook, By Cognitive Disorders (2021-2030) ($MN)
  • Table 18 Global Neurotechnology Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 19 Global Neurotechnology Market Outlook, By Depression (2021-2030) ($MN)
  • Table 20 Global Neurotechnology Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 21 Global Neurotechnology Market Outlook, By Sleep Disorder (2021-2030) ($MN)
  • Table 22 Global Neurotechnology Market Outlook, By Hearing Conditions (2021-2030) ($MN)
  • Table 23 Global Neurotechnology Market Outlook, By Essential Tremor (2021-2030) ($MN)
  • Table 24 Global Neurotechnology Market Outlook, By Other Conditions (2021-2030) ($MN)
  • Table 25 Global Neurotechnology Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Global Neurotechnology Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 27 Global Neurotechnology Market Outlook, By Homecare Facilities (2021-2030) ($MN)
  • Table 28 Global Neurotechnology Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 29 Global Neurotechnology Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.